The expression level of Smad4 in the serum and cancer tissues of NSCLC patients is decreased and the decreased Smad4 is related to poorly differentiated cancer, lymphatic metastasis and advanced TNM staging. The gene discussed is SMAD4; the disease is non-small cell lung carcinoma.